AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 48 filers reported holding AMPIO PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 0.80 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $9,000 | -18.2% | 19,500 | +0.5% | 0.00% | – |
| Q4 2021 | $11,000 | -65.6% | 19,400 | 0.0% | 0.00% | – |
| Q3 2021 | $32,000 | 0.0% | 19,400 | 0.0% | 0.00% | – |
| Q2 2021 | $32,000 | +540.0% | 19,400 | +83.0% | 0.00% | – |
| Q3 2018 | $5,000 | -78.3% | 10,600 | 0.0% | 0.00% | – |
| Q2 2018 | $23,000 | -90.7% | 10,600 | -67.6% | 0.00% | – |
| Q1 2015 | $246,000 | +119.6% | 32,700 | 0.0% | 0.00% | – |
| Q4 2014 | $112,000 | -2.6% | 32,700 | 0.0% | 0.00% | – |
| Q3 2014 | $115,000 | -66.0% | 32,700 | -19.3% | 0.00% | – |
| Q2 2014 | $338,000 | +49.6% | 40,500 | +13.6% | 0.00% | – |
| Q1 2014 | $226,000 | -10.3% | 35,654 | +0.9% | 0.00% | – |
| Q4 2013 | $252,000 | -22.2% | 35,331 | -18.3% | 0.00% | – |
| Q3 2013 | $324,000 | +32.2% | 43,231 | +1.9% | 0.00% | – |
| Q2 2013 | $245,000 | – | 42,424 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Empery Asset Management, LP | 4,262,409 | $2,430,000 | 5.07% |
| CVI Holdings, LLC | 5,171,896 | $2,948,000 | 0.20% |
| PRIVATE CAPITAL MANAGEMENT LLC | 937,237 | $534,000 | 0.18% |
| CVA Family Office, LLC | 1,137,920 | $649,000 | 0.16% |
| ACT CAPITAL MANAGEMENT, LLC | 291,500 | $166,000 | 0.12% |
| Cypress Capital Management LLC (WY) | 196,775 | $112,000 | 0.09% |
| Willis Investment Counsel | 2,181,840 | $1,244,000 | 0.06% |
| NTB Financial Corp | 146,100 | $83,000 | 0.06% |
| Helen Stephens Group, LLC | 117,222 | $67,000 | 0.05% |
| SRS Capital Advisors, Inc. | 629,172 | $359,000 | 0.05% |